Responding to blood-borne viruses in Australian prisons.

Prisons are a priority setting to reduce the incidence and burden of hepatitis B hepatitis C and HIV in Australia. With high prevalence rates of hep B and hep C in prisons, Australia must ensure the deployment of proven prevention strategies, effective health monitoring and systems that support ready access to treatment across Australia’s prison network, including remand centres and other correctional facilities.

This new paper prepared by Hepatitis Australia, in partnership with AIVL, AFAO and NAPWHA, explores the current responses to blood borne viruses in Australian prisons and puts forward initial strategies to pave the way for a more effective and equitable approach for the prevention, management and treatment of BBVs in Australia’s prisons.